Holen Sie sich die Stockscreener-App
87.16
3.96%
3.32
Schlusskurs vom Vortag:
$83.84
Offen:
$84.01
24-Stunden-Volumen:
1.04M
Relative Volume:
1.09
Marktkapitalisierung:
$4.08B
Einnahmen:
$1.35B
Nettoeinkommen (Verlust:
$163.34M
KGV:
26.60
EPS:
3.2763
Netto-Cashflow:
$189.17M
1W Leistung:
+6.41%
1M Leistung:
+23.67%
6M Leistung:
+20.82%
1J Leistung:
+3.91%
1-Tages-Spanne:
$83.08
$87.32
1-Wochen-Bereich:
$81.50
$87.32
52-Wochen-Spanne:
$47.31
$87.32
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Branche
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
87.16 | 3.92B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Bestätigt | Barrington Research | Outperform |
| 2025-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-06-26 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-02-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
BofA Securities Maintains Haemonetics(HAE.US) With Hold Rating, Raises Target Price to $90 - 富途牛牛
Haemonetics price target raised to $90 from $75 at BofA - TipRanks
Marshall Wace LLP Lowers Holdings in Haemonetics Corporation $HAE - MarketBeat
Norges Bank Makes New $36.82 Million Investment in Haemonetics Corporation $HAE - MarketBeat
Haemonetics (HAE): Reassessing Valuation After a 55% Three-Month Share Price Surge - simplywall.st
Haemonetics (NYSE:HAE) Reaches New 52-Week HighHere's Why - MarketBeat
Haemonetics Corporation $HAE Shares Acquired by Walleye Capital LLC - MarketBeat
XTX Topco Ltd Sells 24,831 Shares of Haemonetics Corporation $HAE - MarketBeat
Should You Be Adding Haemonetics (NYSE:HAE) To Your Watchlist Today? - Yahoo Finance
Capital Fund Management S.A. Makes New $995,000 Investment in Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation (NYSE:HAE) Enhances Medical Innovation - Kalkine Media
Wall Street Zen Upgrades Haemonetics (NYSE:HAE) to "Buy" - MarketBeat
Haemonetics Corporation (NYSE:HAE) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Haemonetics stock hits 52-week high at $85.07 By Investing.com - Investing.com Canada
Haemonetics leverages insights from MassWomen conference - Traders Union
QSV Equity Investors LLC Makes New Investment in Haemonetics Corporation $HAE - MarketBeat
Can Haemonetics Corporation (HAZ) stock sustain free cash flowWeekly Profit Report & Long-Term Capital Growth Ideas - Newser
Will Haemonetics Corporation (HAZ) stock extend growth storyWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Will Haemonetics Corporation (HAZ) stock issue positive guidanceInsider Selling & Real-Time Stock Movement Alerts - Newser
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
3-in-1 TAVR guidewire linked to faster procedures, less radiation - Cardiovascular Business
Fisher Asset Management LLC Cuts Position in Haemonetics Corporation $HAE - MarketBeat
Why Haemonetics Corporation stock could outperform next year2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Blood Bank Information Systems Market Projections 2025-2032: - openPR.com
Top 2 Health Care Stocks You May Want To Dump This Month - Sahm
Haemonetics Corporation $HAE Stock Position Increased by River Road Asset Management LLC - MarketBeat
TradeLink Capital LLC Acquires 5,128 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation $HAE Shares Sold by Schroder Investment Management Group - MarketBeat
Rhumbline Advisers Purchases 5,284 Shares of Haemonetics Corporation $HAE - MarketBeat
How Haemonetics Corporation stock benefits from digital adoptionEarnings Recap Report & Daily Oversold Stock Bounce Ideas - Newser
Can Haemonetics Corporation (HAZ) stock test all time highs2025 Valuation Update & Long-Term Growth Stock Strategies - Newser
Will Haemonetics Corporation stock recover faster than peersStock Surge & Scalable Portfolio Growth Ideas - Newser
Why retail traders accumulate Haemonetics Corporation stockQuarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Boston Partners Buys 11,738 Shares of Haemonetics Corporation $HAE - MarketBeat
Q1 EPS Estimates for Haemonetics Boosted by Zacks Research - MarketBeat
Is There Opportunity in Haemonetics After Shares Surge 57% on Expansion News? - simplywall.st
Q3 EPS Estimates for Haemonetics Decreased by Zacks Research - MarketBeat
Haemonetics Reaches Analyst Target Price - Nasdaq
Haemonetics Corporation $HAE Stock Position Raised by Geode Capital Management LLC - MarketBeat
BTIG Research Reiterates "Buy" Rating for Haemonetics (NYSE:HAE) - MarketBeat
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Barchart.com
Haemonetics stock holds Buy rating at BTIG on plasma segment strength - Investing.com
HAE: BTIG Reiterates Buy Rating with $88 Price Target | HAE Stoc - GuruFocus
How currency fluctuations impact Haemonetics Corporation stockEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
How Haemonetics Corporation (HAZ) stock reacts to fiscal policiesOptions Play & Long-Term Investment Growth Plans - newser.com
Can Haemonetics Corporation stock deliver consistent earnings growthAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Is Haemonetics Corporation stock at risk of policy regulation2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - newser.com
How Haemonetics Corporation stock correlates with oil marketsWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Key metrics from Haemonetics Corporation’s quarterly dataMarket Movers & AI Optimized Trading Strategy Guides - newser.com
Is Haemonetics Corporation stock a buy on weakness2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
How Haemonetics Corporation stock reacts to oil prices2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):